Dock Line
Heidi Overton, in a red jacket, standing in the Oval Office near flags and a golden eagle sculpture, with Robert F. Kennedy Jr. at left
Heidi Overton, in red at right, and Health and Human Services Secretary Robert F. Kennedy Jr., at left, appear in the Oval Office on Aug. 10, 2026, during a White House event at which President Donald Trump signed an executive order regarding childhood vaccines. This photograph is not from this week's nomination withdrawal. Cropped from a 3,000-by-2,000-pixel original, with no upscaling. Official White House photo by Molly Riley; public domain (U.S. government work). Source: https://commons.wikimedia.org/wiki/File:Donald_Trump_signs_an_Executive_Order_regarding_childhood_vaccines_in_the_Oval_Office,_Monday,_August_10,_2026_-_5.jpg (Molly Riley / The White House; public domain (U.S. government work). Source: https://commons.wikimedia.org/wiki/File:Donald_Trump_signs_an_Executive_Order_regarding_childhood_vaccines_in_the_Oval_Office,_Monday,_August_10,_2026_-_5.jpg)

Erastus Smith

November 18, 2026 · 4 min read

White House Withdraws Heidi Overton's Nomination to Lead the FDA

The White House dropped the nomination Tuesday, a day before a scheduled Senate committee vote. Sen. Bill Cassidy said it abandoned a viable path.

The facts come first below. My opinion follows in the section marked as opinion.

The White House has withdrawn the nomination of Dr. Heidi Overton to lead the Food and Drug Administration, according to CBS News and The Guardian. CBS News, citing a senior administration official and other people familiar with the decision, reported that the nomination was dropped Tuesday. A White House official told The Guardian the same.

The Senate Health, Education, Labor and Pensions Committee had been scheduled to vote on the nomination Wednesday, both outlets reported. CBS News said two sources familiar with the matter said the White House shared the decision Tuesday evening, while efforts to lock down Republican votes were still underway.

Sen. Bill Cassidy, R-La., the outgoing chairman of the committee, argued late Tuesday that the issue was not a lack of votes, CBS News reported. He said the "White House abandoned a viable confirmation path." Cassidy wrote that "pro-life Senators sought final assurances from the Administration regarding the Administration's commitment to life issues," and that the administration withdrew Overton rather than make those commitments. "I believe she would have had the votes to pass out of committee and pass the full Senate. My conversations with her convinced me she would follow the science and push back against decisions that put Americans' health at risk," he said, according to CBS News. He also told CBS News that "with the limited time left, confirming a permanent FDA Commissioner will fall to Senate Democrats." Republicans are trying to confirm remaining nominees before Democrats take control of the Senate in January, both outlets reported.

Overton, a physician and White House domestic policy staffer, was nominated by President Donald Trump over the summer, CBS News reported. The Guardian said the nomination came in August and that Overton has spent most of her professional career working directly for Trump or conservative groups aligned with his agenda. CBS News said the FDA, which regulates products that account for about 20% of U.S. consumer spending, has not had a Senate-confirmed leader since Dr. Marty Makary was forced out in May, and that the agency is currently run by acting Commissioner Kyle Diamantas.

The Guardian reported that Overton faced bipartisan questions in the Senate about her willingness to break from Trump, particularly on what the newspaper called his unsupported claims about the dangers of childhood vaccines. Cassidy had previously called Overton's support for Trump's plan to break up combination vaccines, including the measles, mumps and rubella shot, "almost disqualifying," the newspaper said, and had pressed her during a September hearing about her scientific independence and her willingness to push back against Trump and Health and Human Services Secretary Robert F. Kennedy Jr. CBS News said some lawmakers and administration allies had expressed skepticism of Overton in part because of her testimony regarding the FDA-approved abortion drug mifepristone and her work on the president's pro-vape policies.

The Guardian reported that, to win confirmation, Overton would have needed the votes of all 12 Republicans on the committee, where Democrats hold 11 seats. Mini Timmaraju, president of Reproductive Freedom for All, formerly Naral Pro-Choice America, celebrated the withdrawal, the newspaper reported, saying, "Heidi Overton posed a serious threat to the future of medication abortion access." According to The Guardian, Overton wrote in a 2023 policy brief for the America First Policy Institute that Congress should strictly regulate the abortion pill mifepristone "to protect women and children," and that abortion "is corrosive to children, women, and society broadly."

In a Sunday interview on "Face the Nation with Margaret Brennan," Cassidy expressed concern that an acting FDA administrator would have less independence than a Senate-confirmed leader, CBS News reported. "The question is, do we want a series of short-term administrators who probably will have more influence from the secretary, as opposed to someone who may be not, you know, the perfect candidate in somebody's mind, but at least would be a permanent one and have the ability to establish some independence?" he said.

The withdrawal comes as Dock Line has reported that the United States has lost its measles elimination status.

Opinion:

The FDA is not a campaign office. It decides what medicines and foods Americans can trust. A confirmed commissioner should be able to tell the president, and the health secretary, when the evidence does not match the talking points. Cassidy is right to care about that, and right that a string of acting chiefs would leave the agency weaker.

If Cassidy's account is accurate, the White House walked away rather than give pro-life senators a clear word on life issues, including the abortion pill. That is a political choice, not a scientific one. Protecting unborn children is not a fringe demand. Neither is telling the truth about vaccines. The next nominee should follow the evidence, tell the truth, and refuse to treat children or the unborn as expendable. The country still has a narrow window to confirm such a person. It should use it.